• Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience 

      Kiliç, Levent; Karadağ, Ömer; Erden, Abdulsamet; Sari, Alper; Armağan, Berkan; Yardimci, Gözde Kübra; Firat, Esra; Kalyoncu, Umut; Apraş Bilgen, Şule; Kiraz, Sedat; Ertenli, Ihsan; Akdoğan, Ali (TÜBİTAK, 2020-02-13)
      Background/aim: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional ...
    • Tocilizumab Treatment In Juvenile Idiopathic Arthritis Patients: A Single Center Experience 

      Demir, Selcan; Sonmez, Hafize Emine; Arslanoglu-Aydin, Elif; Ozen, Seza; Bilginer, Yelda (2019)
      Tocilizumab is a monoclonal antibody against interleukin-6 that has recently emerged as an alternative treatment modality for juvenile idiopathic arthritis (JIA). In the present study, we aimed to discuss the clinical and ...